background: risk of malignancy index (rmi) is the best method for discriminating benign and malignant pelvic masses. the aim of this study was to determine the rmi for preoperative evaluation of pelvic mass. methods: this study was performed on 182 women with adenexal mass referred to yahyahnejiad hospital of babol university of medical sciences in iran from 2007 to 2009.the sensitivity, specif...

Background: Risk of malignancy index (RMI) is the best method for discriminating benign and malignant pelvic masses. The aim of this study was to determine the RMI for preoperative evaluation of pelvic mass. Methods: This study was performed on 182 women with adenexal mass referred to Yahyahnejiad Hospital of Babol University of Medical Sciences in Iran from 2007 to 2009.The sensitivity, specif...

BACKGROUND The discrimination between benign and malignant adnexal masses is central to decisions regarding clinical management and surgical planning in such patients. PURPOSE OF STUDY To determine if the RMI (RMI 2) can distinguish between benign and malignant adnexal masses. METHODS A prospective cohort study was conducted of 58 women with an adnexal mass referred to a teaching hospital f...

Background: Counselling and rapid referral to a specialised facility might be improved with the use of scoring system that could diagnose ovarian cancer. The relative simplicity Risk Malignancy Index (RMI) technique ease which it may applied make strong candidate as primary diagnostic tool for individuals pelvic masses. Methods: Prospective observations study conducted on women diagnosed mass b...

OBJECTIVE The aim of this study was to evaluate the use of risk of malignancy index (RMI) based on a serum CA125 level, ultrasound findings and menopausal status in primary evaluation of patients with adnexal masses in daily clinical practice. METHODS One hundred and fifty one women with adnexal masses were enrolled. Ultrasound characteristics, menopausal status and serum CA125 level were doc...

BACKGROUND CA125 and HE4 are used in calculating Risk of Malignancy Algorithm (ROMA); and Risk of Malignancy Index (RMI). However, studies showed that normal levels of CA125, and HE4 differ among ethnicities such as between Asians and Caucasians, thus affecting the accuracy of the RMI score and ROMA in predicting ovarian malignancy. This study aimed to determine whether new or modified cutoff v...

OBJECTIVE Differentiation between benign and malignant ovarian neoplasms is essential for creating a system for patient referrals. Therefore, the contributions of the tumor markers CA125 and human epididymis protein 4 (HE4) as well as the risk ovarian malignancy algorithm (ROMA) and risk malignancy index (RMI) values were considered individually and in combination to evaluate their utility for ...